BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Alan Pilgrim is Appointed Chairman of Synexus


10/17/2011 10:53:46 AM

Monday 17th October 2011 -- Alan Pilgrim has taken over as Chairman of Synexus from Professor Trevor Jones, CBE, who continues on the board as a director and becomes President of the Synexus’ Scientific Advisory Board. Synexus, based in Manchester, is the largest multinational organisation dedicated to the recruitment of patients and running of clinical trials at its own Dedicated Research Centres.

Alan Pilgrim, who has had extensive experience in the healthcare services area, recently retired as Group Chief Executive Officer of Europe’s largest diagnostic imaging services company Alliance Medical. Prior to this he turned around the healthcare staffing business Match Group and was Chief Executive Officer of Community Hospitals Group and Group Managing Director of BNA – now known as Nestor. He is a Chartered Accountant by training.

Professor Trevor Jones, CBE, has been Chairman of Synexus since Lyceum Capital took the company private in 2007. Since that time the company has more than doubled its turnover and increased the number of research centres to 26 across nine countries. Trevor is now focussing his attention on the further development and running of the Synexus Scientific Advisory Boards which are composed of world leading specialists in the therapeutic areas where the Synexus model is particularly appropriate.



Read at BioSpace.com

Synexus
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES